Recruiting A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer NCT06292689 Conditions Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more Locations Zhejiang Cancer Hospital — Hangzhou, Zhejiang, China View Trial Details
